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Background: Prior studies demonstrate transradial (TRI) compared to transfemoral coronary intervention (TFI) reduces bleeding complications. 
However, limited cost-effectiveness data are available, specifically neither in large datasets nor in heterogeneous elderly populations at high 
bleeding risk. Our objective was to compare inpatient outcomes and costs of TRI and TFI in Medicare Fee-For-Service beneficiaries.
methods: Elective PCI patients in the ACC NCDR CathPCI Registry® were linked to Centers for Medicare and Medicaid Services (CMS) inpatient and 
outpatient files for years 2009-2010, using probabilistic matching. Bleeding and in-hospital outcomes were obtained from the CathPCI registry while 
costs were ascertained from CMS claims using cost-to-charge ratios. A propensity score for TRI was developed, and a ‘within-hospital’ 2:1 (TFI:TRI) 
propensity matching was performed to reduce confounding. In-hospital outcomes were bleeding, death, MI, stroke, length of stay and cost.
results: There were 6,988 TRI and 13,976 TFI patients compared. TRI patients had shorter length of stay (2.5 vs 2.7 days, p<0.001), less bleeding 
(2.6% vs 4.5%, p<0.001) and lower vascular complications (0.1% vs 0.5%, p<0.001) (Table 1). The costs of TRI were $780 (p<0.001) lower 
compared to TFI.
conclusions: TRI is associated with lower in-hospital costs which are driven by the reduction in bleeding and length of stay in elderly, Medicare 
patients.
Table: In-hospital clinical outcomes and costs of TRI vs TFI 
Total
N = 28,596
TRI
N = 9,532
TFI
N = 19,064
P-value
Length of Stay (days) 2.6 ± 3.5 2.5 ± 2.0 2.7 ± 4.0 < 0.001
In-Hospital Clinical Outcomes
Mortality 87 (0.3%) 23 (0.2%) 64 (0.3%) 0.172
Myocardial Infarction (Biomarker Positive) 566 (2.0%) 174 (1.8%) 392 (2.1%) 0.186
CVA/Stroke 41 (0.1%) 18 (0.2%) 23 (0.1%) 0.151
Combined MACE (Mortality, MI, Stroke) 677 (2.4%) 209 (2.2%) 468 (2.5%) 0.169
In-Hospital Bleeding Outcomes and Vascular Complications
Vascular Complications Requiring Treatment 98 (0.3%) 11 (0.1%) 87 (0.5%) < 0.001
RBC/Whole Blood Transfusion 514 (1.8%) 118 (1.2%) 396 (2.1%) < 0.001
Bleeding 1100 (3.8%) 244 (2.6%) 856 (4.5%) < 0.001
In-Hospital Cost
$13,263
(95% CI $9,342, $18,661)
$12,744
(95% CI $8,885, $18,206)
$13,524
(95% CI $9,576, $18,904)
< 0.001
